PharmTech News

Oct 26, 2017
By Pharmaceutical Technology Editors
The collaboration aims to improve the pharmacokinetics of anti-C3 proteases developed by Catalyst to develop therapeutics for severe eye disorders.
Oct 26, 2017
By Pharmaceutical Technology Editors
Inovio has reported results from a study with non-human primates that showed 100% effectiveness with a DNA vaccine the company is developing with the US Army.
Oct 26, 2017
By Pharmaceutical Technology Editors
The biotechnology company’s drug for treating hives in adults has been granted an expanded indication by the European Commission to treat children and adolescents.
Oct 26, 2017
By Pharmaceutical Technology Editors
The company has opened new facilities and an innovation center in Singapore, China that will focus on the development of plant-based products.
Oct 26, 2017
By Pharmaceutical Technology Editors
The new BioLive event, which will be a global hub for biopharmaceutical manufacturing, will launch alongside CPhI Worldwide 2018 in Madrid.
Oct 25, 2017
By Pharmaceutical Technology Editors
The M&A advisory firm has developed an interactive map of manufacturing sites to give insight into the market size of global manufacturing.
Oct 25, 2017
By Pharmaceutical Technology Editors
Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines.
Oct 25, 2017
By Pharmaceutical Technology Editors
Scott Gottlieb, MD, went before the House Committee on Energy and Commerce to give members the agency’s view on how to fight the opioid crisis, stressing the use of long-term treatment with drug therapy.
Oct 25, 2017
By Pharmaceutical Technology Editors
FDA sent a warning letter to Ridge Properties, LLC, after inspectors found a variety of current good manufacturing practice violations at the company’s Salem, OR facility.
Oct 25, 2017
By Pharmaceutical Technology Editors
Catalent’s new Biologics & Specialty Drug Delivery unit will be led by Barry Littlejohn; Jonathan Arnold to lead Oral Drug Delivery.
native1_300x100
lorem ipsum